A process can be chemically perfect in the lab and still fail on the plant floor. Ask anyone who has lived through a rough technology transfer in API development, and they won’t start with a story about reaction yields – they’ll start with a story about who didn’t talk to whom. Technology transfer is the…
Pharma and chemical projects span R&D, clinical or trial phases, manufacturing, quality control, regulatory approval, and distribution — each with strict timelines, specialized teams, and its own set of dependencies. That complexity is exactly why structured project management has become a strategic necessity for these industries rather than an optional discipline layered on top. A…
Innovation alone isn’t enough — New Product Development has to be fast, compliant, and coordinated across R&D, quality, engineering, and regulatory teams at the same time. The journey from lab bench to launchpad passes through route selection, feasibility studies, process optimization, lab validation, scale-up, and finally commercialization and filing. Each stage depends on inputs from…
New Product Development in pharma is a high-stakes, compliance-driven journey. Most failures aren’t scientific — they’re operational and procedural. A molecule can clear every technical hurdle in the lab and still stall for months because a handoff between R&D and Manufacturing was informal, a regulatory dependency was discovered too late, or nobody owned the decision…
The chemical industry is undergoing a major transformation driven by innovation, regulatory pressure, cost optimization, and rising demand for specialized products. In this landscape, Contract Development and Manufacturing Organizations (CDMOs) have emerged as critical strategic partners. Rather than building every capability in-house, pharma and chemical companies increasingly lean on CDMO partners to move faster, reduce…